1. A voluntarily given written signed dated informed consent from subjects and/or legally acceptable representative. <br/ >2. Subjects of either gender and age between 18 and 75 years. <br/ >3. Confirmed diagnosis of mild to moderate COVID-19. (positivity in RTPCR <br/ >2019-nCoV test on respiratory tract specimens). <br/ >4. In case of moderate COVID-19, subjects with CT or Chest X-ray <br/ >documented pneumonia. <br/ >5. Subjects with pyrexia (axillary â?¥37â?? or oral â?¥37.5â??, or rectalâ?¥38â??) <br/ >or either respiratory rate >24/min and <30/min or cough. <br/ >6. Subjects within 7 days from symptom onset or within 48 hours of <br/ >laboratory diagnosis of SARS-CoV2. <br/ >

1. A voluntarily given written signed dated informed consent from subjects and/or legally acceptable representative. <br/ >2. Subjects of either gender and age between 18 and 75 years. <br/ >3. Confirmed diagnosis of mild to moderate COVID-19. (positivity in RTPCR <br/ >2019-nCoV test on respiratory tract specimens). <br/ >4. In case of moderate COVID-19, subjects with CT or Chest X-ray <br/ >documented pneumonia. <br/ >5. Subjects with pyrexia (axillary â?¥37â?? or oral â?¥37.5â??, or rectalâ?¥38â??) <br/ >or either respiratory rate >24/min and <30/min or cough. <br/ >6. Subjects within 7 days from symptom onset or within 48 hours of <br/ >laboratory diagnosis of SARS-CoV2. <br/ >

1. A voluntarily given written signed dated informed consent from subjects and/or legally acceptable representative. <br/ >2. Subjects of either gender and age between 18 and 75 years. <br/ >3. Confirmed diagnosis of mild to moderate COVID-19. (positivity in RTPCR <br/ >2019-nCoV test on respiratory tract specimens). <br/ >4. In case of moderate COVID-19, subjects with CT or Chest X-ray <br/ >documented pneumonia. <br/ >5. Subjects with pyrexia (axillary â?¥37â?? or oral â?¥37.5â??, or rectalâ?¥38â??) <br/ >or either respiratory rate >24/min and <30/min or cough. <br/ >6. Subjects within 7 days from symptom onset or within 48 hours of <br/ >laboratory diagnosis of SARS-CoV2. <br/ >

1. A voluntarily given written signed dated informed consent from subjects and/or legally acceptable representative. <br/ >2. Subjects of either gender and age between 18 and 75 years. <br/ >3. Confirmed diagnosis of mild to moderate COVID-19. (positivity in RTPCR <br/ >2019-nCoV test on respiratory tract specimens). <br/ >4. In case of moderate COVID-19, subjects with CT or Chest X-ray <br/ >documented pneumonia. <br/ >5. Subjects with pyrexia (axillary â?¥37â?? or oral â?¥37.5â??, or rectalâ?¥38â??) <br/ >or either respiratory rate >24/min and <30/min or cough. <br/ >6. Subjects within 7 days from symptom onset or within 48 hours of <br/ >laboratory diagnosis of SARS-CoV2. <br/ >